Abstract Details
Nancy R. Foldvary-Schaefer, DO, FAAN
(Cleveland Clinic)
PRESENTER |
Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. |
No disclosure on file | |
Richard Schwab, MD (University of Pennsylvania Medical Center) | No disclosure on file |
Jean-Louis Pepin | No disclosure on file |
No disclosure on file | |
No disclosure on file | |
No disclosure on file | |
Geert K. Mayer, MD, PhD (Philipps-Universität Marburg) | Dr. Mayer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen, Idorsia, NLS Pharma. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia, Takeda. Dr. Mayer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Idorsia. |
No disclosure on file | |
Michelle Baladi, PhD (Jazz Pharmaceuticals) | Dr. Baladi has stock in Jazz Pharmaceuticals . |
Patricia Chandler | No disclosure on file |
No disclosure on file | |
No disclosure on file |